← Calendar
Readoutin 164d
Sanofi Pasteur, a Sanofi Company — PCV21 vaccine
Phase 3 primary completion: Study of a 4-Dose Regimen of a 21-valent Pneumococcal Conjugate Vaccine in Healthy Infants From Approximately 2 Months of Age.
- Date
- May 2027
- Type
- Readout
- Indication
- Pneumococcal Immunization
Source ↗Add to calendar
Get told when this date moves
The weekly brief is free. Pro adds reminders 7 days and 1 day before.
More from Sanofi Pasteur, a Sanofi Company
Dec2026
Readoutin 13d
Sanofi Pasteur, a Sanofi Company — PCV21Phase 3 primary completion: Study of the Safety and Immunogenicity of Catch-up Vaccination With a 21-valent Pneumococcal Conjugate Vaccine (PCV21) in Healthy Infants, Toddlers, Children, and Adolescents.